Emerald Acquisition’s iRadimed IRMD Stock Holding History

Emerald Acquisition’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-46,444	Closed	-$1.01M	–	3010
2016 Q2	$1.01M	Buy	+46,444	New	+$836K	﹤0.01%	2172

Other funds holding IRMD

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Emerald Acquisition's IRMD Position: Q3 2016 in Review

Emerald Acquisition sold out of iRadimed (IRMD) in Q3 2016, closing a stake of 46,444 shares — an estimated $1.01M sold.

Emerald Acquisition first reported a position in IRMD in Q2 2016 and held it in 1 quarter. The position peaked at $1.01M in Q2 2016. 62 funds tracked by Wall St. Rank hold IRMD as of Q3 2016.

Emerald Acquisition reported no remaining iRadimed position as of Q3 2016 after selling out during the quarter.
Emerald Acquisition sold 46,444 iRadimed shares in Q3 2016, an estimated $1.01M.
Emerald Acquisition first reported a position in iRadimed in Q2 2016 and held it in 1 quarter.
Emerald Acquisition's iRadimed position peaked at $1.01M in Q2 2016.
62 funds tracked by Wall St. Rank held iRadimed as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.